209 related articles for article (PubMed ID: 34747697)
1. The role of TAp63γ and P53 point mutations in regulating DNA repair, mutational susceptibility and invasion of bladder cancer cells.
Wang HT; Lee HW; Weng MW; Liu Y; Huang WC; Lepor H; Wu XR; Tang MS
Elife; 2021 Nov; 10():. PubMed ID: 34747697
[TBL] [Abstract][Full Text] [Related]
2. TAp63γ enhances nucleotide excision repair through transcriptional regulation of DNA repair genes.
Liu J; Lin M; Zhang C; Wang D; Feng Z; Hu W
DNA Repair (Amst); 2012 Feb; 11(2):167-76. PubMed ID: 22056305
[TBL] [Abstract][Full Text] [Related]
3. Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.
Silva TA; Azevedo H
J Proteomics; 2020 Oct; 229():103951. PubMed ID: 32860965
[TBL] [Abstract][Full Text] [Related]
4. Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing.
Wang F; Dong X; Yang F; Xing N
Front Genet; 2022; 13():831146. PubMed ID: 35419031
[No Abstract] [Full Text] [Related]
5. A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer.
Daizumoto K; Yoshimaru T; Matsushita Y; Fukawa T; Uehara H; Ono M; Komatsu M; Kanayama HO; Katagiri T
Cancer Res; 2018 May; 78(9):2233-2247. PubMed ID: 29440146
[TBL] [Abstract][Full Text] [Related]
6. Dynamic expression changes between non-muscle-invasive bladder cancer and muscle-invasive bladder cancer.
Zhao YG; Shi BY; Qian YY; Bai HW; Xiao L; He XY
Tumori; 2014; 100(6):e273-81. PubMed ID: 25688510
[TBL] [Abstract][Full Text] [Related]
7. Association between DNA repair gene polymorphisms and p53 alterations in Japanese patients with muscle-invasive bladder cancer.
Sakano S; Matsumoto H; Yamamoto Y; Kawai Y; Eguchi S; Ohmi C; Matsuyama H; Naito K
Pathobiology; 2006; 73(6):295-303. PubMed ID: 17374967
[TBL] [Abstract][Full Text] [Related]
8. Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.
Franco R; Zappavigna S; Gigantino V; Luce A; Cantile M; Cerrone M; Facchini G; Perdonà S; Pignata S; Di Lorenzo G; Chieffi S; Vitale G; De Sio M; Sgambato A; Botti G; Yousif AM; Novellino E; Grieco P; Caraglia M
J Exp Clin Cancer Res; 2014 Jun; 33(1):48. PubMed ID: 24893613
[TBL] [Abstract][Full Text] [Related]
9. Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites.
Nassar AH; Umeton R; Kim J; Lundgren K; Harshman L; Van Allen EM; Preston M; Dong F; Bellmunt J; Mouw KW; Choueiri TK; Sonpavde G; Kwiatkowski DJ
Clin Cancer Res; 2019 Apr; 25(8):2458-2470. PubMed ID: 30593515
[TBL] [Abstract][Full Text] [Related]
10. TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.
Spiesbach K; Tannapfel A; Mössner J; Engeland K
Int J Cancer; 2005 Apr; 114(4):555-62. PubMed ID: 15578720
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1.
Devanand P; Kim SI; Choi YW; Sheen SS; Yim H; Ryu MS; Kim SJ; Kim WJ; Lim IK
FEBS J; 2014 Dec; 281(24):5581-601. PubMed ID: 25284287
[TBL] [Abstract][Full Text] [Related]
12. Bladder cancer invasion predictability based on preoperative neutrophil-lymphocyte ratio.
Kaynar M; Yıldırım ME; Badem H; Caviş M; Tekinarslan E; Istanbulluoğlu MO; Karataş ÖF; Çimentepe E
Tumour Biol; 2014 Jul; 35(7):6601-5. PubMed ID: 24696263
[TBL] [Abstract][Full Text] [Related]
13. The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M.
Sun JX; Xia QD; Zhong XY; Liu Z; Wang SG
Front Cell Infect Microbiol; 2023; 13():1182322. PubMed ID: 37351184
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563
[TBL] [Abstract][Full Text] [Related]
15. TAp63gamma regulates hOGG1 and repair of oxidative damage in cancer cell lines.
Upadhyay S; Chatterjee A; Trink B; Sommer M; Ratovitski E; Sidransky D
Biochem Biophys Res Commun; 2007 May; 356(4):823-8. PubMed ID: 17399686
[TBL] [Abstract][Full Text] [Related]
16. A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer.
Piao XM; Kang HW; Jeong P; Byun YJ; Lee HY; Kim K; Seo SP; Kim WT; Lee JY; Ha YS; Choi YH; Moon SK; Yun SJ; Kim WJ
Urol Oncol; 2021 Apr; 39(4):237.e21-237.e29. PubMed ID: 33339725
[TBL] [Abstract][Full Text] [Related]
17. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS
Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419
[TBL] [Abstract][Full Text] [Related]
18. ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
Papadimitriou MA; Avgeris M; Levis PK; Tokas T; Stravodimos K; Scorilas A
J Cancer Res Clin Oncol; 2019 Dec; 145(12):3075-3087. PubMed ID: 31595333
[TBL] [Abstract][Full Text] [Related]
19. Utility of SAM68 in the progression and prognosis for bladder cancer.
Zhang Z; Yu C; Li Y; Jiang L; Zhou F
BMC Cancer; 2015 May; 15():364. PubMed ID: 25944080
[TBL] [Abstract][Full Text] [Related]
20. Mutational Landscape of Bladder Cancer in Mexican Patients:
Pérez-Montiel MD; Cerrato-Izaguirre D; Sánchez-Pérez Y; Diaz-Chavez J; Cortés-González CC; Rubio JA; Jiménez-Ríos MA; Herrera LA; Scavuzzo A; Meneses-García A; Hernández-Martínez R; Vaca-Paniagua F; Ramírez A; Orozco A; Cantú-de-León D; Prada D
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]